CM
ARCK

Crestline Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Crestline Management’s Portfolio ARCK Stock Details ARCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,000
Closed -$251K – 298
2022
Q2 		$251K Buy
+25,000
New +$251K 0.03% 193

Other funds holding ARCK

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Crestline Management's ARCK Position: Q3 2022 in Review

Crestline Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q3 2022, closing a stake of 25,000 shares — an estimated $251K sold.

Crestline Management first reported a position in ARCK in Q2 2022 and held it in 1 quarter. The position peaked at $251K in Q2 2022. 62 funds tracked by Wall St. Rank hold ARCK as of Q3 2022.

  • Crestline Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Crestline Management sold 25,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q3 2022, an estimated $251K.
  • Crestline Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q2 2022 and held it in 1 quarter.
  • Crestline Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $251K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q3 2022.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.